Showing results (71-80 of 197) with videos related to

Sort By:
Pageof 20
Molecular Carcinogenesis|December 14, 2011
Possible involvement of Wnt11 in colorectal cancer progressionMitsuaki Nishioka, Koji Ueno, Shoichi Hazama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 27, 2025
[A Case of Conversion Surgery after SOX+Nivolumab Treatment for Metastatic Gastric Cancer]Masahiro Kitahara, Toshiyuki Fujii, Himawari Kihara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[A Case of Hepatocellular Carcinoma with a Vp4 Tumor Thrombus Treated by Multidisciplinary Therapy]Keisuke Ohta, Yoshihiro Tokuhisa, Takao Tamesa, et al.
BMC Cancer|October 16, 2015
Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET studyHitoshi Soda, Hiromichi Maeda, Junichi Hasegawa, et al.
Anticancer Research|December 27, 2011
Impact of chemotherapy for colorectal cancer on regulatory T-cells and tumor immunityKazunari Maeda, Shoichi Hazama, Kazuhisa Tokuno, et al.
BMJ Open|June 4, 2016
Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C3) studyTakeshi Nagasaka, Hideyuki Mishima, Akira Sawaki, et al.
Medicine|June 21, 2024
Rectal squamous cell carcinoma treated with neoadjuvant fluorouracil, oxaliplatin, cetuximab, and radiation: A case report of pathological complete responseYuta Fujise, Shoichi Hazama, Toshiyuki Fujii, et al.
Japanese Journal of Clinical Oncology|February 10, 2011
Prospective phase II study of FOLFIRI for mCRC in Japan, including the analysis of UGT1A1 28/6 polymorphismsYusuke Okuyama, Shoichi Hazama, Hiroshi Nozawa, et al.
Journal of Cancer|December 7, 2018
Efficacy of CapeOX plus Cetuximab Treatment as a First-Line Therapy for Patients with Extended RAS/BRAF/PIK3CA Wild-Type Advanced or Metastatic Colorectal CancerShigeyoshi Iwamoto, Hiromichi Maeda, Shoichi Hazama, et al.
Cancer Science|July 12, 2019
Genomic profiles of colorectal carcinoma with liver metastases and newly identified fusion genesTakafumi Oga, Yoshihiro Yamashita, Manabu Soda, et al.
Pageof 20